Operating Lease, Right-of-Use Asset of INTEGRA LIFESCIENCES HOLDINGS CORP from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
INTEGRA LIFESCIENCES HOLDINGS CORP quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • INTEGRA LIFESCIENCES HOLDINGS CORP Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $140,568,000, a 2.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $140,568,000 -$3,474,000 -2.4% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $138,187,000 -$8,155,000 -5.6% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $136,572,000 -$10,900,000 -7.4% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $138,463,000 -$13,371,000 -8.8% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $144,042,000 -$12,142,000 -7.8% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $146,342,000 -$10,418,000 -6.6% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $147,472,000 -$1,179,000 -0.79% 30 Jun 2024 10-Q 29 Jul 2024 2024 Q2
Q1 2024 $151,834,000 +$5,320,000 +3.6% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $156,184,000 +$7,900,000 +5.3% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $156,760,000 +$8,490,000 +5.7% 30 Sep 2023 10-Q 25 Oct 2023 2023 Q3
Q2 2023 $148,651,000 +$3,516,000 +2.4% 30 Jun 2023 10-Q 27 Jul 2023 2023 Q2
Q1 2023 $146,514,000 +$64,870,000 +79% 31 Mar 2023 10-Q 26 Apr 2023 2023 Q1
Q4 2022 $148,284,000 +$63,741,000 +75% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $148,270,000 +$60,670,000 +69% 30 Sep 2022 10-Q 26 Oct 2022 2022 Q3
Q2 2022 $145,135,000 +$55,961,000 +63% 30 Jun 2022 10-Q 27 Jul 2022 2022 Q2
Q1 2022 $81,644,000 -$9,530,000 -10% 31 Mar 2022 10-Q 27 Apr 2022 2022 Q1
Q4 2021 $84,543,000 +$908,000 +1.1% 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 $87,600,000 +$2,684,000 +3.2% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $89,174,000 -$4,206,000 -4.5% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $91,174,000 -$4,716,000 -4.9% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $83,635,000 -$10,895,000 -12% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $84,916,000 -$12,822,000 -13% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $93,380,000 -$4,403,000 -4.5% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $95,890,000 +$30,891,000 +48% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $94,530,000 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 $97,738,000 30 Sep 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 $97,783,000 30 Jun 2019 10-Q 25 Jul 2019 2019 Q2
Q1 2019 $64,999,000 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.